Literature DB >> 16545375

Plasmodium vivax: isotopic, PicoGreen, and microscopic assays for measuring chloroquine sensitivity in fresh and cryopreserved isolates.

Varakorn Kosaisavee1, Rossarin Suwanarusk, François Nosten, Dennis E Kyle, Marion Barrends, James Jones, Ric Price, Bruce Russell, Usa Lek-Uthai.   

Abstract

In vitro susceptibility tests provide information on the intrinsic response of Plasmodium vivax to antimalarials, free from confounding factors such as host immunity or relapse. This study examined the utility of radioisotope and PicoGreen assays as alternatives to the traditional microscopic examination for assessing response of P. vivax to antimalarial drugs. There was no significant difference in the mean chloroquine IC(50) of P. vivax (n=40) as determined by the microscopic (33.4 ng/ml), isotopic (33.6 ng/ml), and PicoGreen (39.1 ng/ml) assays, respectively (F=0.239, df=2, 51, and p=0.788). However measurement of IC(50)s by the microscopic method was slightly more successful in producing valid assays (57%), compared to the isotopic (32.5%) and PicoGreen (45.5%) methods. In a paired comparison of 20 fresh and cryopreserved isolates as examined by the microscopic method, there were no significant differences between the mean IC(50) responses (T=1.58, df=15, and p=0.34). Detailed methodologies for the short time culture of field and cryopreserved P. vivax are described. Although the microscopic in vitro assay provides a useful method for characterizing the drug susceptibility phenotype of P. vivax isolates, its utility is limited by a laborious methodology and need for highly skilled microscopists. Future efforts should focus on further development of high throughput assays such as the PicoGreen assay as described in this study.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16545375     DOI: 10.1016/j.exppara.2006.02.006

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  25 in total

1.  The presence of leukocytes in ex vivo assays significantly increases the 50-percent inhibitory concentrations of artesunate and chloroquine against Plasmodium vivax and Plasmodium falciparum.

Authors:  S Kaewpongsri; K Sriprawat; R Suwanarusk; D E Kyle; U Lek-Uthai; M Leimanis; K M Lwin; A P Phyo; J Zwang; B Russell; F Nosten; L Renia
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

2.  Methylene blue inhibits the asexual development of vivax malaria parasites from a region of increasing chloroquine resistance.

Authors:  Rossarin Suwanarusk; Bruce Russell; Alice Ong; Kanlaya Sriprawat; Cindy S Chu; Aung PyaePhyo; Benoit Malleret; François Nosten; Laurent Renia
Journal:  J Antimicrob Chemother       Date:  2014-08-21       Impact factor: 5.790

3.  Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening.

Authors:  Jacob D Johnson; Richard A Dennull; Lucia Gerena; Miriam Lopez-Sanchez; Norma E Roncal; Norman C Waters
Journal:  Antimicrob Agents Chemother       Date:  2007-03-19       Impact factor: 5.191

4.  Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.

Authors:  David J Bacon; Christine Latour; Carmen Lucas; Olga Colina; Pascal Ringwald; Stéphane Picot
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

5.  Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.

Authors:  Edgie-Mark A Co; Richard A Dennull; Drew D Reinbold; Norman C Waters; Jacob D Johnson
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

6.  Amplification of pvmdr1 associated with multidrug-resistant Plasmodium vivax.

Authors:  R Suwanarusk; M Chavchich; B Russell; A Jaidee; F Chalfein; M Barends; B Prasetyorini; E Kenangalem; K A Piera; U Lek-Uthai; N M Anstey; E Tjitra; F Nosten; Q Cheng; R N Price
Journal:  J Infect Dis       Date:  2008-11-15       Impact factor: 5.226

7.  Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture.

Authors:  Céline Borlon; Bruce Russell; Kanlaya Sriprawat; Rossarin Suwanarusk; Annette Erhart; Laurent Renia; François Nosten; Umberto D'Alessandro
Journal:  Int J Parasitol       Date:  2011-12-27       Impact factor: 3.981

8.  In vitro susceptibility of Plasmodium vivax to antimalarials in Colombia.

Authors:  Diana Fernández; César Segura; Margarita Arboleda; Giovanny Garavito; Silvia Blair; Adriana Pabón
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

Review 9.  Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax.

Authors:  Ric N Price; Sarah Auburn; Jutta Marfurt; Qin Cheng
Journal:  Trends Parasitol       Date:  2012-10-05

10.  Haemoglobin interference and increased sensitivity of fluorimetric assays for quantification of low-parasitaemia Plasmodium infected erythrocytes.

Authors:  Carlos Moneriz; Patricia Marín-García; José M Bautista; Amalia Diez; Antonio Puyet
Journal:  Malar J       Date:  2009-12-04       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.